Brief: Ryvu Therapeutics Allots 4.8 Mln J Series Shares
22/12/2022 16:33
Dec 22 (Reuters) - Ryvu Therapeutics SA RVU.WA :
* ALLOTS 4.8 MILLION J SERIES SHARES
* REDUCTION RATE FOR INDIVIDUAL INVESTORS AT 55.51%
* TOTAL ISSUE VALUE AT 250.3 MILLION ZLOTYS
Source text for Eikon: ID:nEM3zyCtWa
Further company coverage: RVU.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Q1 Net Loss 12.6 Million Zlotys
Brief: Ryvu Therapeutics Updates Romacyclib Development Strategy
Brief: Ryvu Therapeutics FY Net Loss At 101.2 Mln Zlotys
Brief: Ryvu Therapeutics Extends Research Collaboration And Exclusive License Agreement With BioNTech Until Nov 29, 2028
Brief: Ryvu Therapeutics Signs Grant Agreement With Poland's NCBR For PERO Project